As HIF plays a key role in metabolism, we hypothesized that induction of HIF-1α or alterations in glycolytic metabolism may be the mechanism by which cancers regulate NKT cell responses [66], by either presenting activating or inhibitory lipid antigen in the context of CD1d. This evidence concerns the gene CD1D and cancer.